BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27777027)

  • 1. Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases.
    Liu KT; Wan JF; Zhu J; Li GC; Sun WJ; Shen LJ; Cai SJ; Gu WL; Lian P; Zhang Z
    Cancer Radiother; 2016 Dec; 20(8):805-810. PubMed ID: 27777027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative chemoradiotherapy for rectal cancer: experience from one centre].
    Lescut N; Lepinoy A; Schipman B; Cerda T; Guimas V; Bednarek C; Bosset JF
    Cancer Radiother; 2015 Apr; 19(2):98-105. PubMed ID: 25769650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
    Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
    J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.
    Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z
    Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
    Sun Y; Wu X; Zhang Y; Lin H; Lu X; Huang Y; Chi P
    Eur J Surg Oncol; 2019 Jul; 45(7):1225-1231. PubMed ID: 30879932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
    Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.
    Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA
    Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.
    Cho H; Kim JE; Kim KP; Yu CS; Kim JC; Kim JH; Lee MA; Jang HS; Oh ST; Kim SY; Oh JH; Kim DY; Hong YS; Kim TW
    Am J Clin Oncol; 2016 Dec; 39(6):623-629. PubMed ID: 27322695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome.
    Hess V; Winterhalder R; von Moos R; Widmer L; Stocker P; Jermann M; Herrmann R; Koeberle D
    Clin Colorectal Cancer; 2017 Sep; 16(3):240-245. PubMed ID: 27687815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
    Bae HW; Kim HS; Yang SY; Kim HS; Shin SJ; Chang JS; Koom WS; Kim NK
    Eur J Surg Oncol; 2021 Nov; 47(11):2814-2820. PubMed ID: 34024668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for pulmonary metastases after curative resection of rectal cancer without preoperative chemoradiotherapy.
    Watanabe K; Saito N; Sugito M; Ito M; Kobayashi A; Nishizawa Y
    Dis Colon Rectum; 2011 Aug; 54(8):989-98. PubMed ID: 21730788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma.
    Zhu J; Lian P; Liu F; Xu Y; Xu J; Guan Z; Liang L; Wang M; Cai S; Zhang Z
    Radiat Oncol; 2013 Jan; 8():10. PubMed ID: 23295152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study.
    Kim JW; Kim YB; Kim NK; Min BS; Shin SJ; Ahn JB; Koom WS; Seong J; Keum KC
    Radiat Oncol; 2010 Aug; 5():75. PubMed ID: 20804559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation.
    Bensignor T; Brouquet A; Dariane C; Thirot-Bidault A; Lazure T; Julié C; Nordlinger B; Penna C; Benoist S
    Colorectal Dis; 2015 Jun; 17(6):491-8. PubMed ID: 25524450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study.
    Bisschop C; van Dijk TH; Beukema JC; Jansen RLH; Gelderblom H; de Jong KP; Rutten HJT; van de Velde CJH; Wiggers T; Havenga K; Hospers GAP
    Ann Surg Oncol; 2017 Sep; 24(9):2632-2638. PubMed ID: 28560600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.
    Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.